PELOBIOTECH

PELOBiotech is a specialized provider of cell culture products and technologies, serving the research and pre-clinical development sectors within cell therapy and regenerative medicine. The company operates a dual business model, selling a broad third-party portfolio while also developing and manufacturing its own proprietary brand, Cellovations®, for cell culture media. With a focus on animal component-free solutions and 3D cell culture, it aims to enhance reproducibility and advance therapeutic development. As a private company, it generates revenue through product sales and services to academic, biotech, and pharmaceutical clients worldwide.

Provider of a comprehensive cell culture ecosystem including animal component-free (ACF) media, one of the world's largest portfolios of human/animal cells, 3D culture technologies, and proprietary Cellovations® brand media. Focus on enabling reproducible research and therapy development.

Operates in the highly competitive life science tools sector, competing against giants like Thermo Fisher, Merck KGaA, and Sartorius, as well as numerous specialty vendors. Differentiation is based on a broad 'one-stop-shop' portfolio, a focus on ACF/3D technologies, and the proprietary Cellovations® brand.